| |
| |
|
| Insider
Information: |
Gordon Murdo |
| Relationship: |
EVP, Global Commercial... |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
102,098 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$18,557,956 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
102,098 |
|
|
| Total
Value |
$18,557,956 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 4.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
EVP, Chief Commercial ... |
2018-08-01 |
49,424 |
|
0 |
Premium* |
|
|
Amgen Inc |
AMGN |
EVP, Global Commercial... |
2024-05-07 |
52,674 |
2018-11-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
54 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMGN |
Amgen Inc |
EVP Global Commercial Ops |
• • – |
2018-11-02 |
4 |
A |
$0.00 |
$0 |
D/D |
34,213 |
34,213 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP Global Commercial Ops |
• • – |
2019-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
4,511 |
39,236 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP Global Commercial Ops |
• • – |
2019-11-02 |
4 |
D |
$217.95 |
$1,266,725 |
D/D |
(5,812) |
34,024 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP Global Commercial Ops |
• • – |
2020-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
3,469 |
37,873 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP Global Commercial Ops |
• • – |
2020-11-02 |
4 |
D |
$216.94 |
$1,359,997 |
D/D |
(6,269) |
32,036 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP Global Commercial Ops |
• • – |
2021-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
17,989 |
50,159 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP Global Commercial Ops |
• • – |
2021-03-19 |
4 |
D |
$244.42 |
$2,197,091 |
D/D |
(8,989) |
41,458 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP Global Commercial Ops |
• • – |
2021-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
4,172 |
45,630 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP Global Commercial Ops |
• • – |
2021-05-03 |
4 |
D |
$239.64 |
$187,398 |
D/D |
(782) |
44,848 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP Global Commercial Ops |
• • – |
2021-11-02 |
4 |
D |
$209.79 |
$1,171,677 |
D/D |
(5,585) |
39,602 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP Global Commercial Ops |
• • – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
9,989 |
49,682 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP Global Commercial Ops |
• • – |
2022-03-18 |
4 |
D |
$235.86 |
$1,178,121 |
D/D |
(4,995) |
44,865 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP Global Commercial Ops |
• • – |
2022-05-02 |
4 |
A |
$0.00 |
$0 |
D/D |
4,330 |
49,195 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP Global Commercial Ops |
• • – |
2022-05-03 |
4 |
D |
$230.92 |
$186,583 |
D/D |
(808) |
48,387 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP Global Commercial Ops |
• • – |
2022-05-05 |
4 |
D |
$236.10 |
$142,368 |
D/D |
(603) |
47,784 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP Global Commercial Ops |
• • – |
2022-08-22 |
4 |
GD |
$0.00 |
$0 |
D/D |
400 |
47,484 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP Global Commercial Ops |
• • – |
2023-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
7,947 |
55,621 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Chief Commercial Officer |
• – – |
2016-07-01 |
4 |
D |
$73.78 |
$89,348 |
D/D |
(1,211) |
13,739 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Chief Commercial Officer |
• – – |
2016-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,335 |
14,950 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Chief Commercial Officer |
• – – |
2016-08-01 |
4 |
D |
$76.19 |
$59,733 |
D/D |
(784) |
14,466 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Chief Commercial Officer |
• – – |
2016-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,511 |
15,250 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Chief Commercial Officer |
• – – |
2017-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
764 |
17,748 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Chief Commercial Officer |
• – – |
2017-03-10 |
4 |
D |
$58.32 |
$747,487 |
D/D |
(12,817) |
27,241 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Chief Commercial Officer |
• – – |
2017-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,592 |
35,898 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Chief Commercial Officer |
• – – |
2017-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(764) |
20,567 |
0 |
- |
|
54 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
